“In the IPR Chapter, India has not breached the trips agrement and is in compliance with domestic law. Are part of the deals, “The government official said.

The work group on access to medicines and treatment is a network of patients, activists and professionals working towards access to affordable medicines in India. It said the UK-India FTA Provisions on Patents Tilt the Balance in Favor of the Patent Owner and Undermine Access to Medicines.

“There is a Progressive Movement Towards Accepting the Demands of FTA Partners, which is systematically debating the public interest safillable in the Indian Pents Act. Regarding Trips and Public Health Measures, clearly places voluntary mechanisms such as voluntary licensing as the preferred and optimal route to Promote access to media, “the work group said.

Biswajit Dhar, A Trade Policy Expert with the Council for Social Development, Said That The Provisions In The UK Deal Favouring Voluntary Licances Leave Access in the Hands in the Hands of Maket Forces. Government in facilitating access.

“Further, it also gives a clear signal to potential compulsory license applicants that they are not welcome. Often, voluntary licences connotation on the licensee to brings to bring share. To Compulsory Licences, “Dhar Said.

“There are also also provisions in the iP chapter who can potentially undermine the safuguards preventing of patents. And Examination of the Parties’ of this provision would lead to the harmonization of Patenability Criteria and SAFURDS 3 (D) of the Patents Act, Gopher. Co-convenor of the work group on access to medicines and treatments.

Compared to the European Free Trade Association (EFTA) IP Chapter, This Chapter Shows Further Movement Towards Strengthening the interests of Patent Holders at the cost of access to media. The implementation of these provisions Reduces of the Ability of the central and state governments to fulfil their constitution on the right to health, the work group said.